Advanced Viral Research (OTCBB: ADVR) is a bio-pharmaceutical company that has been working on an amazing immunomodulator type drug they call "Product R".Product R appears to treat a variety of illnesses including AIDS,HPV and Rheumatoid Arthritis.Even though this company has struggled for survival in the past, as a committed investor in ADVR I am completely convinced that they will succeed in their efforts to bring this drug to market.At the current stock price of 30 cents a share I believe the rewards for an investor getting in on the ground floor of this company's product launch exceeds the risk involved in obtaining FDA approval.This is one company I believe will be worth your time to check out so you can decide for yourself whether or not these things are true.